What question did this study set out to answer?

This systematic review aims to evaluate how discontinuing GLP-1 receptor agonists affects liver-related parameters.

March 13, 2026

Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis

Puntos clave

This systematic review aims to evaluate how discontinuing GLP-1 receptor agonists affects liver-related parameters.
Conducted a systematic review and meta-analysis of relevant studies
Analyzed outcomes related to liver parameters after discontinuation of GLP-1 agonists
Sourced data from PubMed and Embase
Discontinuation leads to significant changes in liver-related parameters
Results indicate potential implications for patient care during transitions in therapy
Data support a need for careful monitoring after stopping GLP-1 treatments

Resumen

The authors declare no conflicts of interest. All articles in this manuscript are available from PubMed and Embase. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70642. Data S1: dom70642-sup-0001-Supinfo.docx. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Me gusta

Guardar

Cite This Study

Souza et al. (Mon,) studied this question.

synapsesocial.com/papers/69b3aad702a1e69014ccb95b https://doi.org/https://doi.org/10.1111/dom.70642

Me gusta

Guardar